3D Medicines Inc. discloses that the authorized share capital remained at 500 million ordinary shares, each with a par value of HKD 0.001, reflecting a total of HKD 500,000 as of November 30, 2025. The issued share count also remained unchanged at 258,177,000 ordinary shares, with no treasury shares reported.

The share option scheme continued to have 12,802,850 outstanding options at the end of the month, without new share issuances or transfers. No funds were raised from the exercise of any options during this period.